查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1293532

富血小板血漿市場：按來源類型（同種異體、自體、同種異體）、按應用 - 俄烏衝突和高通貨膨脹 - 2023-2030 年全球預測

Platelet Rich Plasma Market by Source Type (Allogenic, Autologous, Homologous), Application (Cosmetic Surgery, General Surgery, Neurosurgery) - Russia Ukraine Conflict and High Inflation - Global Forecast 2023-2030
出版日期: | 出版商: 360iResearch | 英文 181 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計2023年全球富血小板血漿市場將達到3.8163億美元，複合年增長率為12.34%，大幅增長，2030年將達到8.4854億美元。

FPNV定位矩陣

FPNV定位矩陣對於評估全球富血小板血漿市場至關重要。 通過檢查業務戰略和產品滿意度的關鍵指標，我們對供應商進行全面評估，使您能夠根據您的具體需求做出明智的決策。 這種高級分析將供應商分為四個像限，並取得了不同程度的成功：前沿 (F)、探路者 (P)、利基 (N) 和重要 (V)。

市場份額分析

市場份額分析可以深入了解供應商在特定市場區域的當前狀態。 比較供應商對整體收入、客戶群和其他關鍵指標的貢獻，可以幫助公司更好地了解他們在爭奪市場份額時的表現以及面臨的情況。 該分析還揭示了特定行業的競爭程度、積累和分散的優勢以及研究基準年的合併特徵。

本報告提供了以下幾點見解：

1. 市場滲透率：提供有關主要公司所服務的市場的全面資訊。

2. 市場開發：提供有關利潤豐厚的新興市場的詳細資訊，並分析其在成熟市場領域的滲透率。

3. 市場多元化：提供有關新產品發布、未開發地區、最新開發和投資的詳細資訊。

4.市場趨勢：全面了解俄羅斯-烏克蘭衝突和高通脹。

5.競爭評估和資訊：對主要公司的市場份額、戰略、產品、認證、監管狀況、專利狀況、製造能力進行綜合評估。

6. 產品開發和創新：提供對未來技術、研發活動和突破性產品開發的見解。

此報告回答了以下問題：

1.富血小板血漿的全球市場規模和預測是多少？

2. 在預測期內，COVID-19 對全球富血小板血漿市場的影響有哪些抑制因素和影響？

3. 在預測期內，全球富血小板血漿市場需要投資哪些產品/細分市場/應用/領域？

4. 你們在全球富血小板血漿市場上的競爭策略是什麼？

5.全球富血小板血漿市場的技術趨勢和監管框架是什麼？

6.全球富血小板血漿市場主要廠商的市場份額如何？

7. 哪些形式和戰略舉措被認為適合進入富血小板血漿全球市場？

目錄

第 1 章前言

第 2 章研究方法

第 3 章執行摘要

第 4 章市場概述

第 5 章市場洞察

  • 市場動態
    • 促進因素
      • 全球範圍內運動相關傷害的發生率正在上升
      • 在肌肉骨骼和骨科疾病治療中的可能應用
      • 越來越多地在整容手術和自然癒合過程中使用
    • 抑制因素
      • 血小板血漿治療效果的不確定性
    • 機會
      • 再生醫學的新應用
      • 對富含血小板血漿的生物活性分子進行持續的研發活動
    • 課題
      • 富含血小板血漿產品的臨床試驗和報銷政策的供應有限
  • 市場趨勢
  • 新冠肺炎 (COVID-19) 的累積影響
  • 俄羅斯-烏克蘭衝突的累積影響
  • 高通脹的累積影響
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 監管框架
  • 客戶定制

第 6 章按來源類型劃分的富血小板血漿市場

  • 同種異體
  • 自體來源
  • 同源

第 7 章富血小板血漿市場：按應用分類

  • 整容手術
  • 普通外科
  • 神經外科
  • 骨科

第 8 章美洲富血小板血漿市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第 9 章亞太地區富血小板血漿市場

  • 澳大利亞
  • 中國
  • 印度
  • 印度尼西亞
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第 10 章歐洲、中東和非洲的富血小板血漿市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 意大利
  • 荷蘭
  • 尼日利亞
  • 挪威
  • 波蘭
  • 卡塔爾
  • 俄羅斯
  • 沙特阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合酋長國
  • 英國

第 11 章競爭態勢

  • FPNV定位矩陣
  • 市場份額分析：主要公司
  • 競爭情景分析：主要公司

第 12 章上市公司名單

第 13 章附錄

  • 討論指南
  • 關於許可證和價格
Product Code: MRR-035AB9C0DA85

The Global Platelet Rich Plasma Market is forecasted to grow significantly, with a projected USD 381.63 million in 2023 at a CAGR of 12.34% and expected to reach a staggering USD 848.54 million by 2030.

The the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Platelet Rich Plasma Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Platelet Rich Plasma Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Source Type, market is studied across Allogenic, Autologous, and Homologous. The Autologous commanded largest market share of 44.31% in 2022, followed by Homologous.

Based on Application, market is studied across Cosmetic Surgery, General Surgery, Neurosurgery, and Orthopedic Surgery. The General Surgery commanded largest market share of 22.35% in 2022, followed by Neurosurgery.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 39.64% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Platelet Rich Plasma Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Platelet Rich Plasma Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Platelet Rich Plasma Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Platelet Rich Plasma Market?

4. What is the competitive strategic window for opportunities in the Global Platelet Rich Plasma Market?

5. What are the technology trends and regulatory frameworks in the Global Platelet Rich Plasma Market?

6. What is the market share of the leading vendors in the Global Platelet Rich Plasma Market?

7. What modes and strategic moves are considered suitable for entering the Global Platelet Rich Plasma Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Platelet Rich Plasma Market, by Source Type, 2022 vs 2030
  • 4.3. Platelet Rich Plasma Market, by Application, 2022 vs 2030
  • 4.4. Platelet Rich Plasma Market, by Region, 2022 vs 2030

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing Incidences of Sports-Related Injuries Globally
      • 5.1.1.2. Potential Application in the Treatment of Musculoskeletal Conditions and Orthopedic Disorders
      • 5.1.1.3. Increasing Use in Cosmetic Surgery and for Natural Healing Process
    • 5.1.2. Restraints
      • 5.1.2.1. Uncertainty on Therapeutic Efficacy of Platelet Rich Plasma
    • 5.1.3. Opportunities
      • 5.1.3.1. Emerging Application in Regenerative Medicine
      • 5.1.3.2. Ongoing Research and Development Activities on Platelet-Rich Plasma Derived Bioactive Molecules
    • 5.1.4. Challenges
      • 5.1.4.1. Limited Availability of Clinical Trials and Reimbursement Policies of Platelet-rich Plasma Products
  • 5.2. Market Trends
  • 5.3. Cumulative Impact of COVID-19
  • 5.4. Cumulative Impact of Russia-Ukraine Conflict
  • 5.5. Cumulative Impact of High Inflation
  • 5.6. Porter's Five Forces Analysis
    • 5.6.1. Threat of New Entrants
    • 5.6.2. Threat of Substitutes
    • 5.6.3. Bargaining Power of Customers
    • 5.6.4. Bargaining Power of Suppliers
    • 5.6.5. Industry Rivalry
  • 5.7. Value Chain & Critical Path Analysis
  • 5.8. Regulatory Framework
  • 5.9. Client Customization

6. Platelet Rich Plasma Market, by Source Type

  • 6.1. Introduction
  • 6.2. Allogenic
  • 6.3. Autologous
  • 6.4. Homologous

7. Platelet Rich Plasma Market, by Application

  • 7.1. Introduction
  • 7.2. Cosmetic Surgery
  • 7.3. General Surgery
  • 7.4. Neurosurgery
  • 7.5. Orthopedic Surgery

8. Americas Platelet Rich Plasma Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Platelet Rich Plasma Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Platelet Rich Plasma Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. FPNV Positioning Matrix
  • 11.2. Market Share Analysis, By Key Player
  • 11.3. Competitive Scenario Analysis, By Key Player

12. List of Company Mentioned

13. Appendix

  • 13.1. Discussion Guide
  • 13.2. License & Pricing

1. APEX Biologix, LLC

2. Arthrex, Inc.

3. Biotest AG

4. Celling Biosciences, Inc.

5. China Biologic Products Holdings, Inc.

6. CSL Limited

7. Dr PRP USA LLC

8. Eclipse

9. EmCyte Corporation

10. Estar Technologies Ltd.

11. Exactech, Inc.

12. Glofinn Oy

13. Johnson & Johnson

14. Juventix Regenerative Medical, LLC

15. Stryker Corporation

16. Terumo BCT, Inc.

17. ThermoGenesis Holdings, Inc.

18. Zimmer Biomet Holdings, Inc.

LIST OF FIGURES

  • FIGURE 1. PLATELET RICH PLASMA MARKET RESEARCH PROCESS
  • FIGURE 2. PLATELET RICH PLASMA MARKET SIZE, 2022 VS 2030
  • FIGURE 3. PLATELET RICH PLASMA MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2022 VS 2030 (%)
  • FIGURE 5. PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2022 VS 2030 (%)
  • FIGURE 6. PLATELET RICH PLASMA MARKET SIZE, BY REGION, 2022 VS 2030 (%)
  • FIGURE 7. PLATELET RICH PLASMA MARKET DYNAMICS
  • FIGURE 8. PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 9. PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS PLATELET RICH PLASMA MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 11. UNITED STATES PLATELET RICH PLASMA MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 12. ASIA-PACIFIC PLATELET RICH PLASMA MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 13. EUROPE, MIDDLE EAST & AFRICA PLATELET RICH PLASMA MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 14. PLATELET RICH PLASMA MARKET, FPNV POSITIONING MATRIX, 2022
  • FIGURE 15. PLATELET RICH PLASMA MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

  • TABLE 1. PLATELET RICH PLASMA MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
  • TABLE 3. PLATELET RICH PLASMA MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD MILLION)
  • TABLE 5. PLATELET RICH PLASMA MARKET SIZE, BY ALLOGENIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 6. PLATELET RICH PLASMA MARKET SIZE, BY AUTOLOGOUS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. PLATELET RICH PLASMA MARKET SIZE, BY HOMOLOGOUS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 9. PLATELET RICH PLASMA MARKET SIZE, BY COSMETIC SURGERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. PLATELET RICH PLASMA MARKET SIZE, BY GENERAL SURGERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. PLATELET RICH PLASMA MARKET SIZE, BY NEUROSURGERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. PLATELET RICH PLASMA MARKET SIZE, BY ORTHOPEDIC SURGERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. AMERICAS PLATELET RICH PLASMA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 14. AMERICAS PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD MILLION)
  • TABLE 15. AMERICAS PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 16. ARGENTINA PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD MILLION)
  • TABLE 17. ARGENTINA PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 18. BRAZIL PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD MILLION)
  • TABLE 19. BRAZIL PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 20. CANADA PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD MILLION)
  • TABLE 21. CANADA PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 22. MEXICO PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD MILLION)
  • TABLE 23. MEXICO PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 24. UNITED STATES PLATELET RICH PLASMA MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 25. UNITED STATES PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. UNITED STATES PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 27. ASIA-PACIFIC PLATELET RICH PLASMA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 28. ASIA-PACIFIC PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. ASIA-PACIFIC PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 30. AUSTRALIA PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. AUSTRALIA PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 32. CHINA PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. CHINA PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 34. INDIA PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. INDIA PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 36. INDONESIA PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. INDONESIA PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 38. JAPAN PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. JAPAN PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 40. MALAYSIA PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. MALAYSIA PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 42. PHILIPPINES PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. PHILIPPINES PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 44. SINGAPORE PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. SINGAPORE PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 46. SOUTH KOREA PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. SOUTH KOREA PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 48. TAIWAN PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. TAIWAN PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 50. THAILAND PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. THAILAND PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. VIETNAM PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. VIETNAM PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 54. EUROPE, MIDDLE EAST & AFRICA PLATELET RICH PLASMA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 55. EUROPE, MIDDLE EAST & AFRICA PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. EUROPE, MIDDLE EAST & AFRICA PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. DENMARK PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. DENMARK PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 59. EGYPT PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. EGYPT PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 61. FINLAND PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. FINLAND PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 63. FRANCE PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. FRANCE PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. GERMANY PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. GERMANY PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 67. ISRAEL PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. ISRAEL PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. ITALY PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. ITALY PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. NETHERLANDS PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. NETHERLANDS PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 73. NIGERIA PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. NIGERIA PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 75. NORWAY PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. NORWAY PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. POLAND PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. POLAND PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 79. QATAR PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. QATAR PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. RUSSIA PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. RUSSIA PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 83. SAUDI ARABIA PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. SAUDI ARABIA PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 85. SOUTH AFRICA PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH AFRICA PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. SPAIN PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. SPAIN PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. SWEDEN PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. SWEDEN PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 91. SWITZERLAND PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. SWITZERLAND PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. TURKEY PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. TURKEY PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 95. UNITED ARAB EMIRATES PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. UNITED ARAB EMIRATES PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. UNITED KINGDOM PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED KINGDOM PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. PLATELET RICH PLASMA MARKET, FPNV POSITIONING MATRIX, 2022
  • TABLE 100. PLATELET RICH PLASMA MARKET SHARE, BY KEY PLAYER, 2022
  • TABLE 101. PLATELET RICH PLASMA MARKET LICENSE & PRICING